J Vet Sci.  2001 Apr;2(1):53-58.

Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis

Abstract

With the aim of establishing bio-indices for the development of multistep hepatotumorigenesis, rats were fed water containing 0.01% diethylnitrosamine (DEN) ad libitum for 13 weeks. This treatment with DEN only made it possible to induce hepatic tumors in 100%. After the DEN administration, several clinical symptoms were observed including minor behavioral changes, brittleness of hair and a decrease in water and food intake. The concentration of total serum protein and albumin in all treated groups was significantly lower than in non-treated controls (p<0.05). Increase of specific enzyme (AST, ALT and GGT) activity (p<0.05), variable tumor size and hepatomegaly of the liver was observed in all rats treated with DEN for 10 weeks. Both hepatocellular carcinoma and cholangiocarcinoma were found in the same livers at the same time, and were prominently developed after 12 weeks. In case of carcinoma, some of the livers showed more or less advanced states over the 12-15 weeks period. In the present study, hepatocellular carcinoma was developed by treating DEN in only the drinking water, without any other carcinogens or without partial hepatectomy. These results indicate that DEN is a new carcinogen that acts directly on it the liver, moreover, it might be very useful for investigating hepatotumorigenesis.

Keyword

Diethylnitrosamine; tumorigenesis; hepatocellular carcinoma; enzyme activity; rat

MeSH Terms

Alanine Transaminase/blood
Animals
Aspartate Aminotransferases/blood
Biological Markers/blood
Carcinogens
*Cell Transformation, Neoplastic
Diethylnitrosamine/toxicity
Liver/drug effects/*pathology
Liver Neoplasms/blood/chemically induced/*pathology
Liver Neoplasms, Experimental/blood/*pathology
Male
Rats
Rats, Sprague-Dawley
gamma-Glutamyltransferase/blood
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr